Acarix AB
STO:ACARIX
Acarix AB
Research & Development
Acarix AB
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Acarix AB
STO:ACARIX
|
Research & Development
-kr14.8m
|
CAGR 3-Years
19%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Elekta AB (publ)
STO:EKTA B
|
Research & Development
-kr21m
|
CAGR 3-Years
72%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
CellaVision AB
STO:CEVI
|
Research & Development
-kr97.6m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-14%
|
|
|
Getinge AB
STO:GETI B
|
Research & Development
-kr1.3B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
N/A
|
|
|
Arjo AB (publ)
STO:ARJO B
|
Research & Development
-kr140m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
S
|
Stille AB
STO:STIL
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Acarix AB
Glance View
Acarix AB is engaged in the provision of medical devices for monitoring Coronary Artery Disease. The company is headquartered in Malmo, Skane. The company went IPO on 2016-12-19. The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
See Also
What is Acarix AB's Research & Development?
Research & Development
-14.8m
SEK
Based on the financial report for Dec 31, 2025, Acarix AB's Research & Development amounts to -14.8m SEK.
What is Acarix AB's Research & Development growth rate?
Research & Development CAGR 5Y
0%
Over the last year, the Research & Development growth was 42%. The average annual Research & Development growth rates for Acarix AB have been 19% over the past three years .
